<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<measures><measure><type>Main</type><parent-measure></parent-measure><title>Total number of offices who participated in a quarterly briefing in the month (1)</title><dictionary>FDA-TRACK briefings are held quarterly to discuss the analysis and progress of performance measures set forth by Centers and offices.  Key attendees may include the Commissioner, Principal Deputy Commissioner, Center Directors, Office Directors, and Office of Planning (OPL) leads.  Attendance by the offices allows key stakeholders to fully collaborate on the analysis of performance measures and receive thorough feedback on performance measure progress.</dictionary><footnotes><note>(1) This measure will no longer be tracked after October 2011.</note></footnotes><measure-description>Number</measure-description><chart-type></chart-type><chart-color></chart-color><right-min></right-min><right-max></right-max><fiscal-year><chart-min>0</chart-min><chart-max></chart-max><title>2010</title><target-header></target-header><target-description></target-description><summary></summary><time><frame>Oct 2009</frame><target></target><value>0</value></time><time><frame>Nov 2009</frame><target></target><value>5</value></time><time><frame>Dec 2009</frame><target></target><value>9</value></time><time><frame>Jan 2010</frame><target></target><value>2</value></time><time><frame>Feb 2010</frame><target></target><value>2</value></time><time><frame>Mar 2010</frame><target></target><value>9</value></time><time><frame>Apr 2010</frame><target></target><value>10</value></time><time><frame>May 2010</frame><target></target><value>44</value></time><time><frame>Jun 2010</frame><target></target><value>41</value></time><time><frame>Jul 2010</frame><target></target><value>10</value></time><time><frame>Aug 2010</frame><target></target><value>46</value></time><time><frame>Sep 2010</frame><target></target><value>46</value></time></fiscal-year><fiscal-year><chart-min>0</chart-min><chart-max></chart-max><title>2011</title><target-header></target-header><target-description></target-description><summary></summary><time><frame>Oct 2010</frame><target></target><value>33</value></time><time><frame>Nov 2010</frame><target></target><value>49</value></time><time><frame>Dec 2010</frame><target></target><value>22</value></time><time><frame>Jan 2011</frame><target></target><value>50</value></time><time><frame>Feb 2011</frame><target></target><value>18</value></time><time><frame>Mar 2011</frame><target></target><value>60</value></time><time><frame>Apr 2011</frame><target></target><value>41</value></time><time><frame>May 2011</frame><target></target><value>19</value></time><time><frame>Jun 2011</frame><target></target><value>21</value></time><time><frame>Jul 2011</frame><target></target><value>31</value></time><time><frame>Aug 2011</frame><target></target><value>34</value></time><time><frame>Sep 2011</frame><target></target><value>46</value></time></fiscal-year><fiscal-year><chart-min></chart-min><chart-max></chart-max><title>2012</title><target-header></target-header><target-description></target-description><summary></summary><time><frame>Oct 2011</frame><target></target><value>23</value></time></fiscal-year></measure><related-links><link><url>http://www.fda.gov/AboutFDA/Transparency/track/ucm206211.htm</url><text>FDA-TRACK OC Administrative Offices Dashboard</text></link></related-links><glossary></glossary></measures>਍††਍਍਍਍਍਍਍